Benzodiazepines and related drugs are initiated frequently in persons with Alzheimer’s disease already before the diagnosis, and their use becomes even more common after the diagnosis, shows a recent study from the University of Eastern Finland.

These drugs were initiated more frequently in persons with Alzheimer’s disease than in persons not diagnosed with AD. Compared to persons not diagnosed with AD, it was three times more likely for persons with Alzheimer’s disease to initiate benzodiazepine use after the diagnosis, and benzodiazepines were most commonly initiated six months after the diagnosis.

READ FULL ARTICLE Curated publisher From News Medical